OCGN Stock Analysis

OCGN -  USA Stock  

USD 6.57  0.03  0.46%

The latest indifference towards the small price fluctuations of Ocugen Inc may encourage institutional investors to take a closer look at the company as it is trading at a share price of 6.57 on 22,557,300 in trading volume. The company executives did not add any value to Ocugen investors in May. However, most investors can still diversify their portfolios with Ocugen Inc to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 10.18. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Ocugen partners.
Please check Your Equity Center.

Search Stock Analysis 

The Ocugen stock analysis report makes it easy to digest most publicly released information about Ocugen and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. OCGN stock analysis module also helps to analyze the Ocugen price relationship with some important fundamental indicators such as market cap and management efficiency.

OCGN Stock Analysis Notes

The company has price-to-book ratio of 0.15. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Ocugen Inc recorded a loss per share of 427.27. The entity had not issued any dividends in recent years. The firm had a split on the 30th of September 2019. Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing and Bharat Biotech for the commercialization of COVAXIN in the United States market. Ocugen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 15 people. To find out more about Ocugen Inc contact the company at 484 328 4701 or learn more at http://www.ocugen.com.

Ocugen Inc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Ocugen's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Ocugen Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Ocugen Inc has very high historical volatility over the last 90 days
Ocugen Inc has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 42.62 K. Net Loss for the year was (37.5 M) with loss before overhead, payroll, taxes, and interest of (5.1 M).
Ocugen Inc currently holds about 44.79 M in cash with (15.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23.
Latest headline from www.fool.com: Will This News Stop Ocugen Shares in Their Tracks - Motley Fool

Ocugen Inc Upcoming and Recent Events

Earnings reports are used by Ocugen to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Ocugen previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report26th of March 2021
Next Earnings Report14th of May 2021
Next Fiscal Quarter End31st of December 2020
Next Fiscal Year End26th of March 2021
Last Quarter Report30th of September 2020
Last Earning Announcement31st of December 2019

OCGN Largest EPS Surprises

Earnings surprises can significantly impact Ocugen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Ocugen SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Ocugen prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Ocugen investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Ocugen Inc specific information freely available to individual and institutional investors to make a timely investment decision.
26th of January 2021
Unclassified Corporate Event
12th of January 2021
Submission of Matters to a Vote of Security Holders
8th of January 2021
Financial Statements and Exhibits. Other Events
5th of January 2021
Financial Statements and Exhibits. Regulation FD Disclosure
28th of December 2020
Submission of Matters to a Vote of Security Holders
22nd of December 2020
Financial Statements and Exhibits. Other Events
6th of November 2020
Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition
20th of October 2020
Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition

OCGN Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Ocugen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ocugen Inc backward and forwards among themselves. Ocugen's institutional investor refers to the entity that pools money to purchase Ocugen's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Vanguard Group IncCommon Shares8.1 M55 M
State Street CorpCommon SharesM34.2 M
Blackrock IncCommon Shares3.4 M23.2 M
Geode Capital Management LlcCommon Shares1.6 M11.1 M
Susquehanna International Group LlpCommon Shares1.3 M9.1 M
Bank Of America CorpPut Options1.3 M8.9 M
Group One Trading LpCall Options905.6 K6.1 M
Citadel Advisors LlcCommon Shares808.7 K5.5 M
Hrt Financial LpCommon Shares570.9 K3.9 M
Note, although Ocugen's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

OCGN Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 1.24 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ocugen's market, we take the total number of its shares issued and multiply it by Ocugen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (30.82) % which means that it has lost $30.82 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (92.79) %, meaning that it created substantial loss on money invested by shareholders. Ocugen management efficiency ratios could be used to measure how well ocugen inc manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 19th of June, Ocugen holds the risk adjusted performance of 0.0073, and Coefficient Of Variation of (31,300). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Ocugen, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Ocugen Inc, which can be compared to its competitors. Please check Ocugen Inc jensen alpha and downside variance to decide if Ocugen Inc is priced some-what accurately, providing market reflects its current price of 6.57 per share. Given that Ocugen has jensen alpha of (0.018673), we recommend you to check out Ocugen Inc's recent market performance to make sure the company can sustain itself at a future point.

Ocugen Inc Price Movement Analysis

The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Mid-point over period is an average of Ocugen Inc highest and lowest values attained during the given period. View also all equity analysis or get more info about midpoint over period overlap studies indicator.

Ocugen Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ocugen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ocugen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ocugen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Potti Manish 2 days ago via Macroaxis 
Exercise of in-the-money or at-the-money derivative position by Potti Manish of 95880 shares of Ocugen
Castillo Kirsten over a week ago via Macroaxis 
Sale by Castillo Kirsten of 10000 shares of Ocugen
Musunuri Shankar over a week ago via Macroaxis 
Exercise or conversion by Musunuri Shankar of 22800 shares of Ocugen subject to Rule 16b-3
Kompella Uday over two weeks ago via Macroaxis 
Exercise or conversion by Kompella Uday of 7191 shares of Ocugen subject to Rule 16b-3
Fernandes Prabhavathi over three weeks ago via Macroaxis 
Exercise or conversion by Fernandes Prabhavathi of 14000 shares of Ocugen subject to Rule 16b-3
Subramanian Sanjay over a month ago via Macroaxis 
Exercise or conversion by Subramanian Sanjay of 31000 shares of Ocugen subject to Rule 16b-3
Potti Manish over a month ago via Macroaxis 
Sale by Potti Manish of 60000 shares of Ocugen
Kumar Ramesh over a month ago via Macroaxis 
Exercise or conversion by Kumar Ramesh of 7500 shares of Ocugen subject to Rule 16b-3
Musunuri Shankar over two months ago via Macroaxis 
Purchase by Musunuri Shankar of 143000 shares of Ocugen
Subramanian Sanjay over three months ago via Macroaxis 
Exercise or conversion by Subramanian Sanjay of 35591 shares of Ocugen subject to Rule 16b-3
Potti Manish over three months ago via Macroaxis 
Acquisition by Potti Manish of 126000 shares of Ocugen subject to Rule 16b-3
Zhang Junge over three months ago via Macroaxis 
Acquisition by Zhang Junge of 126000 shares of Ocugen subject to Rule 16b-3

Ocugen Predictive Daily Indicators

Ocugen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Ocugen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Ocugen Forecast Models

Ocugen time-series forecasting models is one of many Ocugen's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ocugen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Ocugen Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ocugen stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling OCGN shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Ocugen. By using and applying OCGN Stock analysis, traders can create a robust methodology for identifying OCGN entry and exit points for their positions.
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing and Bharat Biotech for the commercialization of COVAXIN in the United States market. Ocugen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 15 people.

Current OCGN Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. OCGN analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. OCGN analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Ocugen Inc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most OCGN analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand OCGN stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Ocugen Inc, talking to its executives and customers, or listening to OCGN conference calls.
OCGN Analyst Advice Details

OCGN Stock Analysis Indicators

Ocugen Inc stock analysis indicators help investors evaluate how Ocugen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Ocugen shares will generate the highest return on investment. By understating and applying Ocugen stock analysis, traders can identify Ocugen position entry and exit signals to maximize returns.
Quick Ratio10.46
Fifty Two Week Low0.19
Shares Short Prior Month37.03M
Average Daily Volume Last 10 Day60.26M
Average Daily Volume In Three Month64.93M
Shares Percent Shares Out21.68%
Short Percent Of Float22.27%
Forward Price Earnings11.59
Float Shares192.52M
Fifty Two Week High18.77
Enterprise Value To Ebitda-74.13
Fifty Day Average9.44
Two Hundred Day Average6.41
Enterprise Value To Revenue28,149.57
Please check Your Equity Center. Note that the Ocugen Inc information on this page should be used as a complementary analysis to other Ocugen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for Ocugen Stock analysis

When running Ocugen Inc price analysis, check to measure Ocugen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocugen is operating at the current time. Most of Ocugen's value examination focuses on studying past and present price action to predict the probability of Ocugen's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Ocugen's price. Additionally, you may evaluate how the addition of Ocugen to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Global Correlations
Find global opportunities by holding instruments from different markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
The market value of Ocugen Inc is measured differently than its book value, which is the value of OCGN that is recorded on the company's balance sheet. Investors also form their own opinion of Ocugen's value that differs from its market value or its book value, called intrinsic value, which is Ocugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocugen's market value can be influenced by many factors that don't directly affect Ocugen Inc underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocugen's value and its price as these two are different measures arrived at by different means. Investors typically determine Ocugen value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.